Cargando…

Important factors associated with sick leave after allogeneic haematopoietic stem cell transplantation—a 1-year prospective study

PURPOSE: This study examines sick leave (SL) and factors associated with full-time SL 1 year after allogeneic haematopoietic stem cell transplantation (allo-HSCT) in patients of working age from 2009 to 2016 (n = 122). METHODS: Questionnaire data were collected on admission to the allo-HSCT unit, at...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eriksson, Linda, Wennman-Larsen, Agneta, Bergkvist, Karin, Ljungman, Per, Winterling, Jeanette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790935/ https://www.ncbi.nlm.nih.gov/pubmed/33417181 http://dx.doi.org/10.1007/s11764-020-00986-5

Ejemplares similares

A person-centred intervention remotely targeting family caregivers’ support needs in the context of allogeneic hematopoietic stem cell transplantation—a feasibility study
por: Kisch, Annika M., et al.
Publicado: (2022)

Expanding the use of allogeneic haematopoietic cell transplantation in dermatology
por: Bauer, J.W.
Publicado: (2021)

Family caregivers’ support needs during allo-HSCT—a longitudinal study
por: Kisch, Annika M., et al.
Publicado: (2020)

The Importance of Secretor-Status in Norovirus Infection Following Allogeneic Hematopoietic Stem Cell Transplantation
por: Swartling, Lisa, et al.
Publicado: (2022)

Genomic prediction of relapse in recipients of allogeneic haematopoietic stem cell transplantation
por: Ritari, J., et al.
Publicado: (2018)

Quality of life in men with metastatic prostate cancer in their final years before death – a retrospective analysis of prospective data
por: Holm, Maja, et al.
Publicado: (2018)

Rehabilitation after Allogeneic Haematopoietic Stem Cell Transplantation: A Special Challenge
por: Bertz, Hartmut
Publicado: (2021)

Early-onset cardiac dysfunction following allogeneic haematopoietic stem cell transplantation
por: Moriyama, Shohei, et al.
Publicado: (2022)

Factors of decisive importance for being in work or not during two years after breast cancer surgery: content analysis of 462 women’s open answers
por: Wennman-Larsen, Agneta, et al.
Publicado: (2021)

Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation
por: Marks, David I, et al.
Publicado: (2011)

Purinergic Signalling in Allogeneic Haematopoietic Stem Cell Transplantation and Graft-versus-Host Disease
por: Cuthbertson, Peter, et al.
Publicado: (2021)

Tumour-reactive B cells and antibody responses after allogeneic haematopoietic cell transplantation
por: de Jong, G., et al.
Publicado: (2020)

Metabolic Profiling Early Post-Allogeneic Haematopoietic Cell Transplantation in the Context of CMV Infection
por: Rasmussen, Kirstine K., et al.
Publicado: (2023)

P1312: CHARACTERISTICS OF MEMBRANOUS NEPHROPATHY AFTER ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Jin, Yue, et al.
Publicado: (2023)

Prostate-specific antigen (PSA) and distress: - a cross-sectional nationwide survey in men with prostate cancer in Sweden
por: Rönningås, Ulrika, et al.
Publicado: (2019)

Parents and children's perceptions of distress related to oral mucositis during haematopoietic stem cell transplantation
por: Kamsvåg‐Magnusson, Tove, et al.
Publicado: (2014)

Allogeneic Haematopoietic Stem Cell Transplantation as Therapy for Chronic Granulomatous Disease—Single Centre Experience
por: Goździk, Jolanta, et al.
Publicado: (2011)

Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016
por: Ullmann, Andrew J., et al.
Publicado: (2016)

Allogeneic haematopoietic stem cell transplantation from SARS-CoV-2 positive donors
por: Leclerc, Mathieu, et al.
Publicado: (2021)

Risk factors and outcomes of diffuse alveolar haemorrhage after allogeneic haematopoietic stem cell transplantation
por: Wu, Jin, et al.
Publicado: (2021)

Prognostic factors affecting the outcome after allogeneic haematopoietic stem cell transplantation for myelodysplastic syndrome
por: Belohlavkova, P, et al.
Publicado: (2021)

Immune Reconstitution After Allogeneic Haematopoietic Cell Transplantation: From Observational Studies to Targeted Interventions
por: Yanir, Asaf, et al.
Publicado: (2022)

Impaired right ventricular function in long-term survivors of allogeneic haematopoietic stem-cell transplantation
por: Massey, Richard John, et al.
Publicado: (2021)

Editorial: Allogeneic haematopoietic stem cell transplantation for children with acute lymphoblastic leukaemia in the era of immunotherapy
por: Peters, Christina, et al.
Publicado: (2022)

The impact of donor type on resource utilisation and costs in allogeneic haematopoietic stem cell transplantation in the Netherlands
por: van Gorkom, Gwendolyn, et al.
Publicado: (2022)

Medication Adherence among Allogeneic Haematopoietic Stem Cell Transplant Recipients: A Systematic Review
por: Visintini, Chiara, et al.
Publicado: (2023)

Sick leave before and after arthroscopic partial meniscectomy due to traumatic meniscal tear
por: Bergkvist, Dan, et al.
Publicado: (2020)

The Impact of CBT on Sick Leave and Health
por: Hägglund, Pathric, et al.
Publicado: (2020)

Association between P2X7 Polymorphisms and Post-Transplant Outcomes in Allogeneic Haematopoietic Stem Cell Transplantation
por: Koldej, Rachel M, et al.
Publicado: (2020)

Erratum to: Allogeneic Haematopoietic Stem Cell Transplantation as Therapy for Chronic Granulomatous Disease—Single Centre Experience
por: Goździk, Jolanta, et al.
Publicado: (2011)

Lymph node tuberculosis after allogeneic haematopoietic stem cell transplantation: an atypical presentation of an uncommon complication
por: Martín-Sánchez, Guillermo, et al.
Publicado: (2015)

Immune recovery and the risk of CMV/ EBV reactivation in children post allogeneic haematopoietic stem cell transplantation
por: Janeczko, Małgorzata, et al.
Publicado: (2016)

Long-term outcome following cyclosporine-related neurotoxicity in paediatric allogeneic haematopoietic stem cell transplantation
por: Straathof, K, et al.
Publicado: (2017)

Refractory autoimmune haemolytic anaemia following allogenic haematopoietic stem cell transplantation: successful treatment of rituximab
por: Li, Xiaofan, et al.
Publicado: (2019)

Immunogenicity of the inactivated influenza vaccine in children who have undergone allogeneic haematopoietic stem cell transplant
por: Ryan, Anne L., et al.
Publicado: (2019)

Cerebellar Neurocysticercosis as Long-Term Complication of Allogeneic Haematopoietic Stem Cell Transplantation from Haploidentical Donor
por: Meconi, Federico, et al.
Publicado: (2019)

Time to revisit the use of G-CSF after allogeneic haematopoietic cell transplantation in COVID-19 era?
por: Malek, Alexandre E.
Publicado: (2021)

Humoral serological response to the BNT162b2 vaccine after allogeneic haematopoietic cell transplantation
por: Yeshurun, Moshe, et al.
Publicado: (2022)

Complicated and persistent severe COVID-19 pneumonia in a recipient of allogeneic haematopoietic stem cell transplant
por: Lazzari, Lorenzo, et al.
Publicado: (2021)

Wharton’s jelly‐derived stromal cells and their cell therapy applications in allogeneic haematopoietic stem cell transplantation
por: Pochon, Cécile, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eme5ni2qt4c7q4k9aoqgg0omb0